CN1857334A - 灵芝孢子油静脉乳注射液及其制备方法 - Google Patents
灵芝孢子油静脉乳注射液及其制备方法 Download PDFInfo
- Publication number
- CN1857334A CN1857334A CN 200510068335 CN200510068335A CN1857334A CN 1857334 A CN1857334 A CN 1857334A CN 200510068335 CN200510068335 CN 200510068335 CN 200510068335 A CN200510068335 A CN 200510068335A CN 1857334 A CN1857334 A CN 1857334A
- Authority
- CN
- China
- Prior art keywords
- injection
- oil
- ganoderma spore
- water
- emulsifying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000222336 Ganoderma Species 0.000 title claims abstract description 93
- 239000000839 emulsion Substances 0.000 title claims abstract description 62
- 238000010253 intravenous injection Methods 0.000 title claims abstract description 39
- 238000000034 method Methods 0.000 title claims description 6
- 238000002347 injection Methods 0.000 claims abstract description 72
- 239000007924 injection Substances 0.000 claims abstract description 72
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 27
- 238000002360 preparation method Methods 0.000 claims abstract description 20
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 14
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 13
- 239000002904 solvent Substances 0.000 claims abstract description 10
- 239000003921 oil Substances 0.000 claims description 141
- 235000019198 oils Nutrition 0.000 claims description 141
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 68
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 60
- 238000003756 stirring Methods 0.000 claims description 54
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 51
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 34
- 239000012071 phase Substances 0.000 claims description 33
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 32
- 210000003022 colostrum Anatomy 0.000 claims description 32
- 235000021277 colostrum Nutrition 0.000 claims description 32
- 239000000243 solution Substances 0.000 claims description 29
- 230000001804 emulsifying effect Effects 0.000 claims description 27
- 239000003795 chemical substances by application Substances 0.000 claims description 23
- 239000008215 water for injection Substances 0.000 claims description 23
- 238000002156 mixing Methods 0.000 claims description 22
- 235000011187 glycerol Nutrition 0.000 claims description 21
- 238000004945 emulsification Methods 0.000 claims description 20
- 238000010438 heat treatment Methods 0.000 claims description 18
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 16
- 229910052757 nitrogen Inorganic materials 0.000 claims description 16
- 238000012856 packing Methods 0.000 claims description 16
- 229960001295 tocopherol Drugs 0.000 claims description 16
- 229930003799 tocopherol Natural products 0.000 claims description 16
- 235000010384 tocopherol Nutrition 0.000 claims description 16
- 239000011732 tocopherol Substances 0.000 claims description 16
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 15
- 210000003462 vein Anatomy 0.000 claims description 14
- 239000003814 drug Substances 0.000 claims description 13
- 238000004659 sterilization and disinfection Methods 0.000 claims description 12
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- 239000008347 soybean phospholipid Substances 0.000 claims description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- 230000001954 sterilising effect Effects 0.000 claims description 9
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 claims description 8
- 235000012424 soybean oil Nutrition 0.000 claims description 8
- 239000003549 soybean oil Substances 0.000 claims description 8
- 238000007670 refining Methods 0.000 claims description 7
- 235000019485 Safflower oil Nutrition 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 235000005713 safflower oil Nutrition 0.000 claims description 6
- 239000003813 safflower oil Substances 0.000 claims description 6
- 210000000582 semen Anatomy 0.000 claims description 6
- 230000003204 osmotic effect Effects 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 4
- 125000003074 decanoyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 238000011068 loading method Methods 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 3
- 239000008346 aqueous phase Substances 0.000 claims description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 3
- 239000000194 fatty acid Substances 0.000 claims description 3
- 239000008103 glucose Substances 0.000 claims description 3
- 235000001727 glucose Nutrition 0.000 claims description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 3
- 230000010494 opalescence Effects 0.000 claims description 3
- 229920001993 poloxamer 188 Polymers 0.000 claims description 3
- 229940044519 poloxamer 188 Drugs 0.000 claims description 3
- 239000000811 xylitol Substances 0.000 claims description 3
- 235000010447 xylitol Nutrition 0.000 claims description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 3
- 229960002675 xylitol Drugs 0.000 claims description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- 238000013019 agitation Methods 0.000 claims description 2
- 239000000084 colloidal system Substances 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 235000010356 sorbitol Nutrition 0.000 claims description 2
- CTKXFMQHOOWWEB-UHFFFAOYSA-N Ethylene oxide/propylene oxide copolymer Chemical compound CCCOC(C)COCCO CTKXFMQHOOWWEB-UHFFFAOYSA-N 0.000 claims 1
- 235000006708 antioxidants Nutrition 0.000 abstract description 9
- 239000003937 drug carrier Substances 0.000 abstract 1
- -1 isoosmotic regulator Substances 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 description 11
- 239000003643 water by type Substances 0.000 description 10
- 238000005303 weighing Methods 0.000 description 10
- 210000000481 breast Anatomy 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 7
- 210000004881 tumor cell Anatomy 0.000 description 7
- 230000000259 anti-tumor effect Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 150000003648 triterpenes Chemical class 0.000 description 3
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000036436 anti-hiv Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 229920001983 poloxamer Polymers 0.000 description 2
- 229960000502 poloxamer Drugs 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 1
- 244000020998 Acacia farnesiana Species 0.000 description 1
- 235000003074 Acacia farnesiana Nutrition 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 1
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 229940124274 edetate disodium Drugs 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 102000027450 oncoproteins Human genes 0.000 description 1
- 108091008819 oncoproteins Proteins 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 125000002640 tocopherol group Chemical group 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2005100683358A CN1857334B (zh) | 2005-05-08 | 2005-05-08 | 灵芝孢子油静脉乳注射液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2005100683358A CN1857334B (zh) | 2005-05-08 | 2005-05-08 | 灵芝孢子油静脉乳注射液及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1857334A true CN1857334A (zh) | 2006-11-08 |
CN1857334B CN1857334B (zh) | 2010-12-15 |
Family
ID=37296322
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2005100683358A Expired - Fee Related CN1857334B (zh) | 2005-05-08 | 2005-05-08 | 灵芝孢子油静脉乳注射液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1857334B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009105912A1 (zh) * | 2008-02-26 | 2009-09-03 | 广州汉方现代中药研究开发有限公司 | 一种灵芝孢子油脂肪乳剂及其质量控制方法与应用 |
CN101601695B (zh) * | 2009-06-26 | 2012-02-29 | 江苏省中医药研究院 | 灵芝三萜提取物的自微乳化纳米组合物及其制备方法 |
CN102640809A (zh) * | 2012-05-18 | 2012-08-22 | 山东三星玉米产业科技有限公司 | 一种具有保健功能的食用调和油 |
CN105832744A (zh) * | 2016-05-17 | 2016-08-10 | 海南合瑞制药股份有限公司 | 一种供注射用的前列地尔冻干乳剂组合物 |
CN113876816A (zh) * | 2020-07-03 | 2022-01-04 | 广州中国科学院先进技术研究所 | 一种油溶性植物提取物乳液 |
CN116210906A (zh) * | 2022-12-30 | 2023-06-06 | 广州白云山汉方现代药业有限公司 | 一种改善口感的灵芝孢子油口服液的制备方法及其应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1239100C (zh) * | 2004-09-10 | 2006-02-01 | 广州汉方现代中药研究开发有限公司 | 灵芝孢子油及其制备方法和用途 |
-
2005
- 2005-05-08 CN CN2005100683358A patent/CN1857334B/zh not_active Expired - Fee Related
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009105912A1 (zh) * | 2008-02-26 | 2009-09-03 | 广州汉方现代中药研究开发有限公司 | 一种灵芝孢子油脂肪乳剂及其质量控制方法与应用 |
DE112008003744T5 (de) | 2008-02-26 | 2011-04-14 | Guangzhou Hanfang Natural Medicine Research & Development Co., Ltd., Guangzhou | Fettemulsion, umfassend Ganoderma-Sporenöl, Verfahren zur Qualitätskontrolle und Verwendung davon |
JP2011513208A (ja) * | 2008-02-26 | 2011-04-28 | グァンツォウ ハンファン ナチュラル メディスン リサーチ アンド ディベロップメント カンパニー リミテッド | レイシ胞子油脂肪乳剤、その品質管理方法および薬物調整への応用方法 |
CN101601695B (zh) * | 2009-06-26 | 2012-02-29 | 江苏省中医药研究院 | 灵芝三萜提取物的自微乳化纳米组合物及其制备方法 |
CN102640809A (zh) * | 2012-05-18 | 2012-08-22 | 山东三星玉米产业科技有限公司 | 一种具有保健功能的食用调和油 |
CN105832744A (zh) * | 2016-05-17 | 2016-08-10 | 海南合瑞制药股份有限公司 | 一种供注射用的前列地尔冻干乳剂组合物 |
CN105832744B (zh) * | 2016-05-17 | 2018-10-30 | 浙江长典医药有限公司 | 一种供注射用的前列地尔冻干乳剂组合物 |
CN113876816A (zh) * | 2020-07-03 | 2022-01-04 | 广州中国科学院先进技术研究所 | 一种油溶性植物提取物乳液 |
CN116210906A (zh) * | 2022-12-30 | 2023-06-06 | 广州白云山汉方现代药业有限公司 | 一种改善口感的灵芝孢子油口服液的制备方法及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN1857334B (zh) | 2010-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1736369A (zh) | 姜黄素乳剂及其制备方法和用途 | |
CN1857334B (zh) | 灵芝孢子油静脉乳注射液及其制备方法 | |
CN1903228A (zh) | 灵芝孢子油自乳化制剂及其制备方法 | |
CN101028461A (zh) | 薏苡仁油自乳化制剂及其制备方法 | |
CN1990032B (zh) | 灵芝孢子油与薏苡仁油复合静脉注射乳剂及其制备方法 | |
CN1813733A (zh) | 维生素e烟酸酯脂质微球注射液及其制备方法 | |
CN1973826A (zh) | 含有依托泊苷的脂质微球注射液及其制备方法 | |
CN1762341A (zh) | 治疗心脑血管疾病、肝脏疾病的丹参酚酸复合物及其应用 | |
CN1686143A (zh) | 十一酸睾酮自乳化软胶囊组合物及制备方法 | |
CN1732936A (zh) | 尼莫地平乳注射液及制备方法 | |
CN1720948A (zh) | 红茴香滴丸及其制备方法 | |
CN1857272A (zh) | 前列地尔小输液及其制备方法 | |
CN1562014A (zh) | 注射用ve烟酸酯乳剂及其制备方法 | |
CN1839842A (zh) | 一种含左西孟旦或其药学上可以接受的盐作为活性成分的药物组合物 | |
CN1297260C (zh) | 脂肪酰乙醛粉针剂及其制备方法 | |
CN1843338A (zh) | 一种丙泊酚注射液的制备工艺 | |
CN1919190A (zh) | 紫杉醇与中药挥发油复合静脉注射乳剂及其制备方法 | |
CN1931158A (zh) | 多西他赛与中药挥发油复合静脉注射乳剂及其制备方法 | |
CN1290495C (zh) | 一种细辛脑脂微球制剂及其制备方法 | |
CN1278676C (zh) | 姜黄素注射制剂及其制备方法 | |
CN1504191A (zh) | 葫芦素脂质体组方及其制剂 | |
CN1457795A (zh) | 葛根黄酮自微乳化软胶囊及其制备方法 | |
CN1235577C (zh) | 以l-精氨酸为生产原料的保健品 | |
CN1262099A (zh) | 阿苯达唑乳剂 | |
CN1528322A (zh) | 齐墩果酸脂肪乳注射剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: TASLY PHARMACEUTICAL GROUP CO., LTD. Free format text: FORMER NAME: TIANJIN TASLY PHARM. CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 300402 Tianjin Beichen Xinyi white road Liaohe Road No. 1 Patentee after: Tasly Pharmaceutical Group Co., Ltd. Address before: 300402 Tianjin Beichen Xinyi white road Liaohe Road No. 1 Patentee before: Tianjin Tianshili Pharmaceutical Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20101215 Termination date: 20180508 |
|
CF01 | Termination of patent right due to non-payment of annual fee |